Trial Profile
Remifentanil for the prevention of microemulsion propofol-induced injection-site pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2012
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Injection site pain
- Focus Therapeutic Use
- 14 Feb 2012 New trial record